STA Pharma completes clinical supply of PhoenixMD’s breast cancer treatment 10-Jun-2019 By Maggie Lynch Clinical trial supply for the first targeted treatment of triple-negative breast cancer completed through PhoenixMD and STA Pharmaceutical agreement.